Ed Penhoet, Ph.D.
Ed joined Alta in 2000 as a Director and has been full time at Alta since 2008. He currently serves on the board of directors of aTyr Pharma, CymaBay Therapeutics, Immune Design, and Scynexis.
A co-founder of Chiron, Ed served as the Company’s President and Chief Executive Officer from its formation in 1981 until April 1998. He served as Vice-Chair of the governing board of the Independent Citizens Oversight Committee for the California Institute of Regenerative Medicine (CIRM) from 2005 to 2010, and served as the President of the Gordon and Betty Moore Foundation from 2004 to 2008.
Ed was recently appointed to President Obama's Council of Advisors on Science and Technology (PCAST). PCAST is an advisory group comprised of 20 of the nation’s leading scientists and engineers who directly advise the President and the Executive Office of the President. PCAST makes policy recommendations in the many areas where understanding of science, technology, and innovation is key to strengthening our economy and forming policy that works for the American people.
For 10 years prior to founding Chiron, Ed was a faculty member of the Biochemistry Department of the University of California, Berkeley.
Ed is the immediate past Dean of the School of Public Health at the University of California, Berkeley. He is a member of both the Institute of Medicine of the National Academies and the American Academy of Arts and Sciences. He has co-authored more than 50 scientific articles and papers.